Literature DB >> 33788282

Zebrafish as a tractable model of human cardiovascular disease.

George Bowley1,2, Elizabeth Kugler1,2,3, Rob Wilkinson4, Allan Lawrie1, Freek van Eeden2,5, Tim J A Chico1,2, Paul C Evans1,2, Emily S Noël2,5, Jovana Serbanovic-Canic1,2.   

Abstract

Mammalian models including non-human primates, pigs and rodents have been used extensively to study the mechanisms of cardiovascular disease. However, there is an increasing desire for alternative model systems that provide excellent scientific value while replacing or reducing the use of mammals. Here, we review the use of zebrafish, Danio rerio, to study cardiovascular development and disease. The anatomy and physiology of zebrafish and mammalian cardiovascular systems are compared, and we describe the use of zebrafish models in studying the mechanisms of cardiac (e.g. congenital heart defects, cardiomyopathy, conduction disorders and regeneration) and vascular (endothelial dysfunction and atherosclerosis, lipid metabolism, vascular ageing, neurovascular physiology and stroke) pathologies. We also review the use of zebrafish for studying pharmacological responses to cardiovascular drugs and describe several features of zebrafish that make them a compelling model for in vivo screening of compounds for the treatment cardiovascular disease. LINKED ARTICLES: This article is part of a themed issue on Preclinical Models for Cardiovascular disease research (BJP 75th Anniversary). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v179.5/issuetoc.
© 2021 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society.

Entities:  

Keywords:  cardiovascular; disease model; endothelial; vascular; zebrafish

Mesh:

Substances:

Year:  2021        PMID: 33788282     DOI: 10.1111/bph.15473

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  Methamphetamine-induced lethal toxicity in zebrafish larvae.

Authors:  Yu Chen; Alexander S Wisner; Isaac T Schiefer; Frederick E Williams; F Scott Hall
Journal:  Psychopharmacology (Berl)       Date:  2022-10-21       Impact factor: 4.415

2.  Expression of Nerve Growth Factor and Its Receptor TrkA in the Reproductive System of Adult Zebrafish.

Authors:  Pietro Cacialli
Journal:  Vet Sci       Date:  2022-05-06

Review 3.  Seeing the Light: The Use of Zebrafish for Optogenetic Studies of the Heart.

Authors:  Jonathan S Baillie; Matthew R Stoyek; T Alexander Quinn
Journal:  Front Physiol       Date:  2021-12-23       Impact factor: 4.566

4.  Simultaneous imaging of calcium and contraction in the beating heart of zebrafish larvae.

Authors:  Jussep Salgado-Almario; Manuel Vicente; Yillcer Molina; Antonio Martinez-Sielva; Pierre Vincent; Beatriz Domingo; Juan Llopis
Journal:  Theranostics       Date:  2022-01-01       Impact factor: 11.556

Review 5.  Zebrafish as a Model to Study Vascular Elastic Fibers and Associated Pathologies.

Authors:  Marie Hoareau; Naïma El Kholti; Romain Debret; Elise Lambert
Journal:  Int J Mol Sci       Date:  2022-02-14       Impact factor: 5.923

6.  Shear stress switches the association of endothelial enhancers from ETV/ETS to KLF transcription factor binding sites.

Authors:  Roman Tsaryk; Nora Yucel; Elvin V Leonard; Noelia Diaz; Olga Bondareva; Maria Odenthal-Schnittler; Zoltan Arany; Juan M Vaquerizas; Hans Schnittler; Arndt F Siekmann
Journal:  Sci Rep       Date:  2022-03-21       Impact factor: 4.379

Review 7.  New Therapeutics Targeting Arterial Media Calcification: Friend or Foe for Bone Mineralization?

Authors:  Astrid Van den Branden; Anja Verhulst; Patrick C D'Haese; Britt Opdebeeck
Journal:  Metabolites       Date:  2022-04-05

Review 8.  Experimental models of Barth syndrome.

Authors:  William T Pu
Journal:  J Inherit Metab Dis       Date:  2021-08-15       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.